VivaGel^TM for prevention of HIV

40 million people are infected with HIV.
Starpharma is developing a solution
for the 6 billion not infected...
and hoping to stay that way.

The desire for sexual intimacy is perhaps the most basic and compelling need that humans experience. Unfortunately, for most of mankind, sexual intercourse carries with it the risk of HIV/AIDS.

Starpharma is developing VivaGel™ vaginal microbicide gel to satisfy the urgent need for a product which is safe, effective for prevention of HIV and does not interfere with or diminish the pleasure of sexual intercourse.

Visit our website to learn more about how Starpharma is employing its world-leading expertise in nanotechnology to develop solutions for HIV/AIDS and other serious human illnesses.